• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗接种对 14 种高危 HPV 型感染的影响:一种数学建模方法。

Impact of vaccination on 14 high-risk HPV type infections: a mathematical modelling approach.

机构信息

Department of Vaccination and Immune Protection, National Institute for Health and Welfare (THL), Helsinki, Finland.

出版信息

PLoS One. 2013 Aug 29;8(8):e72088. doi: 10.1371/journal.pone.0072088. eCollection 2013.

DOI:10.1371/journal.pone.0072088
PMID:24009669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3756967/
Abstract

The development of high-risk human papillomavirus (hrHPV) infection to cervical cancer is a complicated process. We considered solely hrHPV infections, thus avoiding the confounding effects of disease progression, screening, and treatments. To analyse hrHPV epidemiology and to estimate the overall impact of vaccination against infections with hrHPVs, we developed a dynamic compartmental transmission model for single and multiple infections with 14 hrHPV types. The infection-related parameters were estimated using population-based sexual behaviour and hrHPV prevalence data from Finland. The analysis disclosed the important role of persistent infections in hrHPV epidemiology, provided further evidence for a significant natural immunity, and demonstrated the dependence of transmission probability estimates on the model structure. The model predicted that vaccinating girls at 80% coverage will result in a 55% reduction in the overall hrHPV prevalence and a higher 65% reduction in the prevalence of persistent hrHPV infections in females. In males, the reduction will be 42% in the hrHPV prevalence solely by the herd effect from the 80% coverage in girls. If such high coverage among girls is not reached, it is still possible to reduce the female hrHPV prevalence indirectly by the herd effect if also boys are included in the vaccination program. On the other hand, any herd effects in older unvaccinated cohorts were minor. Limiting the epidemiological model to infection yielded improved understanding of the hrHPV epidemiology and of mechanisms with which vaccination impacts on hrHPV infections.

摘要

高危型人乳头瘤病毒(hrHPV)感染发展为宫颈癌是一个复杂的过程。我们仅考虑了 hrHPV 感染,从而避免了疾病进展、筛查和治疗的混杂影响。为了分析 hrHPV 的流行病学,并评估针对 hrHPV 感染的疫苗接种的总体影响,我们针对 14 种 hrHPV 型的单次和多次感染开发了一个动态房室传输模型。使用基于人群的性行为和芬兰的 hrHPV 流行率数据来估计与感染相关的参数。分析揭示了持续性感染在 hrHPV 流行病学中的重要作用,进一步证明了自然免疫力的显著作用,并表明了传输概率估计对模型结构的依赖性。该模型预测,如果以 80%的覆盖率为女孩接种疫苗,将使总体 hrHPV 流行率降低 55%,女性持续性 hrHPV 感染的流行率降低 65%。在男性中,仅通过女孩 80%覆盖率的群体效应,hrHPV 流行率就会降低 42%。如果无法达到如此高的女孩覆盖率,通过群体效应仍然有可能间接地降低女性的 hrHPV 流行率,如果也将男孩纳入疫苗接种计划。另一方面,任何针对年龄较大的未接种人群的群体效应都很小。将流行病学模型限制在感染范围内,可以更好地理解 hrHPV 流行病学以及疫苗接种对 hrHPV 感染的影响机制。

相似文献

1
Impact of vaccination on 14 high-risk HPV type infections: a mathematical modelling approach.疫苗接种对 14 种高危 HPV 型感染的影响:一种数学建模方法。
PLoS One. 2013 Aug 29;8(8):e72088. doi: 10.1371/journal.pone.0072088. eCollection 2013.
2
Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe.评估在欧洲为男童和女童接种 HPV 相关疾病疫苗的临床获益。
BMC Cancer. 2013 Jan 8;13:10. doi: 10.1186/1471-2407-13-10.
3
Modelling the population-level impact of vaccination on the transmission of human papillomavirus type 16 in Australia.模拟疫苗接种对澳大利亚16型人乳头瘤病毒传播的人群水平影响。
Sex Health. 2007 Sep;4(3):147-63. doi: 10.1071/sh07042.
4
Prevalence of genital HPV infections and HPV serology in adolescent girls, prior to vaccination.青少年女性接种疫苗前的生殖器 HPV 感染和 HPV 血清学流行情况。
Cancer Epidemiol. 2012 Dec;36(6):519-24. doi: 10.1016/j.canep.2012.07.006. Epub 2012 Aug 17.
5
Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models.人群水平影响、 herd immunity(群体免疫)和人乳头瘤病毒疫苗接种后的消除:基于传播动力学模型预测的系统评价和荟萃分析。
Lancet Public Health. 2016 Nov;1(1):e8-e17. doi: 10.1016/S2468-2667(16)30001-9. Epub 2016 Sep 27.
6
The estimated impact of natural immunity on the effectiveness of human papillomavirus vaccination.自然免疫对人乳头瘤病毒疫苗效力的预估影响。
Vaccine. 2015 Oct 5;33(41):5357-5364. doi: 10.1016/j.vaccine.2015.08.079. Epub 2015 Sep 5.
7
Assessing the cost-effectiveness of HPV vaccination strategies for adolescent girls and boys in the UK.评估 HPV 疫苗接种策略在英国青少年男孩和女孩中的成本效益。
BMC Infect Dis. 2019 Jun 24;19(1):552. doi: 10.1186/s12879-019-4108-y.
8
Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.芬兰人乳头瘤病毒16型与宫颈癌的流行病学及疫苗接种的潜在影响:数学建模分析
PLoS Med. 2006 May;3(5):e138. doi: 10.1371/journal.pmed.0030138. Epub 2006 Apr 4.
9
Herd immunity effect of the HPV vaccination program in Australia under different assumptions regarding natural immunity against re-infection.澳大利亚 HPV 疫苗接种项目在不同自然感染再免疫假设下的群体免疫效果。
Vaccine. 2013 Apr 8;31(15):1931-6. doi: 10.1016/j.vaccine.2013.02.018. Epub 2013 Feb 19.
10
On the Elimination of Infections Related to Oncogenic Human Papillomavirus: An Approach Using a Computational Network Model.消除与致癌型人乳头瘤病毒相关的感染:基于计算网络模型的方法。
Viruses. 2021 May 13;13(5):906. doi: 10.3390/v13050906.

引用本文的文献

1
Modelling epidemiological and economics processes - the case of cervical cancer.模拟流行病学和经济过程——以宫颈癌为例。
Health Econ Rev. 2025 Feb 22;15(1):13. doi: 10.1186/s13561-024-00589-1.
2
Analysis of cervical HPV infections among unvaccinated young adult women to inform vaccine strategies in this age group: the Costa Rica HPV Vaccine Trial.未接种疫苗的年轻成年女性宫颈人乳头瘤病毒感染情况分析,以指导该年龄组的疫苗接种策略:哥斯达黎加人乳头瘤病毒疫苗试验
Sex Transm Infect. 2022 Jul 16;99(3):180-6. doi: 10.1136/sextrans-2022-055434.
3
Different human papillomavirus types share early natural history transitions in immunocompetent women.

本文引用的文献

1
Inference of type-specific HPV transmissibility, progression and clearance rates: a mathematical modelling approach.基于数学模型的 HPV 型别特异性传播、进展和清除率推断
PLoS One. 2012;7(11):e49614. doi: 10.1371/journal.pone.0049614. Epub 2012 Nov 21.
2
Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model-based analysis.基于模型分析的二价、四价和九价人乳头瘤病毒疫苗的人群影响。
J Natl Cancer Inst. 2012 Nov 21;104(22):1712-23. doi: 10.1093/jnci/djs395. Epub 2012 Oct 27.
3
Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis.
不同类型的人乳头瘤病毒在免疫功能正常的女性中具有相似的早期自然史转变。
Int J Cancer. 2022 Sep 15;151(6):920-929. doi: 10.1002/ijc.34128. Epub 2022 Jun 17.
4
Reduction in Vaccine HPV Type Infections in a Young Women Group (18-25 Years) Five Years after HPV Vaccine Introduction in Colombia.HPV 疫苗接种后五年哥伦比亚年轻女性(18-25 岁)中 HPV 型别感染减少。
Cancer Prev Res (Phila). 2022 Jan;15(1):55-66. doi: 10.1158/1940-6207.CAPR-21-0063. Epub 2021 Oct 5.
5
Effectiveness of various human papillomavirus vaccination strategies: A community randomized trial in Finland.各种人乳头瘤病毒疫苗接种策略的效果:芬兰的一项社区随机试验。
Cancer Med. 2021 Nov;10(21):7759-7771. doi: 10.1002/cam4.4299. Epub 2021 Sep 27.
6
Differing Age-Specific Cervical Cancer Incidence Between Different Types of Human Papillomavirus: Implications for Predicting the Impact of Elimination Programs.不同类型人乳头瘤病毒导致的宫颈癌发病率存在年龄差异:对消除计划影响预测的启示。
Am J Epidemiol. 2021 Apr 6;190(4):506-514. doi: 10.1093/aje/kwaa121.
7
Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is Applied.如果采用性别中立的策略,适度覆盖率的疫苗接种可消除致癌型人乳头瘤病毒。
J Infect Dis. 2020 Aug 17;222(6):948-956. doi: 10.1093/infdis/jiaa099.
8
Does Male Circumcision Reduce Women's Risk of Sexually Transmitted Infections, Cervical Cancer, and Associated Conditions?男性包皮环切术能否降低女性感染性传播感染、患宫颈癌及相关疾病的风险?
Front Public Health. 2019 Jan 31;7:4. doi: 10.3389/fpubh.2019.00004. eCollection 2019.
9
Impacts of human papillomavirus vaccination for different populations: A modeling study.不同人群人乳头瘤病毒疫苗接种的影响:建模研究。
Int J Cancer. 2018 Sep 1;143(5):1086-1092. doi: 10.1002/ijc.31409. Epub 2018 Apr 16.
10
Different Challenges in Eliminating HPV16 Compared to Other Types: A Modeling Study.与其他类型相比,消除人乳头瘤病毒16型面临的不同挑战:一项建模研究
J Infect Dis. 2017 Aug 1;216(3):336-344. doi: 10.1093/infdis/jix299.
两种人乳头瘤病毒疫苗的交叉保护效力:系统评价和荟萃分析。
Lancet Infect Dis. 2012 Oct;12(10):781-9. doi: 10.1016/S1473-3099(12)70187-1. Epub 2012 Aug 22.
4
Occurrence of vaccine and non-vaccine human papillomavirus types in adolescent Finnish females 4 years post-vaccination.青少年芬兰女性接种疫苗后 4 年疫苗和非疫苗型人乳头瘤病毒的发生情况。
Int J Cancer. 2012 Dec 15;131(12):2832-8. doi: 10.1002/ijc.27586. Epub 2012 Apr 30.
5
Potential overestimation of HPV vaccine impact due to unmasking of non-vaccine types: quantification using a multi-type mathematical model.由于非疫苗型别的漏报导致 HPV 疫苗效果的潜在高估:使用多型别数学模型进行定量评估。
Vaccine. 2012 May 14;30(23):3383-8. doi: 10.1016/j.vaccine.2012.03.065. Epub 2012 Apr 3.
6
Impact of vaccine protection against multiple HPV types on the cost-effectiveness of cervical screening.疫苗对多种 HPV 型别的保护作用对宫颈癌筛查成本效益的影响。
Vaccine. 2012 Feb 27;30(10):1813-22. doi: 10.1016/j.vaccine.2012.01.001. Epub 2012 Jan 10.
7
Sex-specific immunization for sexually transmitted infections such as human papillomavirus: insights from mathematical models.性传播感染的性别特异性免疫接种:来自数学模型的见解。
PLoS Med. 2011 Dec;8(12):e1001147. doi: 10.1371/journal.pmed.1001147. Epub 2011 Dec 20.
8
Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.HPV-16/18 AS04 佐剂疫苗对 3 级或更高级别宫颈上皮内瘤变的总体疗效:随机、双盲 PATRICIA 试验的 4 年研究结束时分析。
Lancet Oncol. 2012 Jan;13(1):89-99. doi: 10.1016/S1470-2045(11)70286-8. Epub 2011 Nov 8.
9
Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.HPV-16/18 AS04 佐剂疫苗对非疫苗型致癌 HPV 引起的宫颈感染和癌前病变的交叉保护效力:随机、双盲 PATRICIA 试验的 4 年研究结束时分析。
Lancet Oncol. 2012 Jan;13(1):100-10. doi: 10.1016/S1470-2045(11)70287-X. Epub 2011 Nov 8.
10
Long-term impact of human papillomavirus vaccination on infection rates, cervical abnormalities, and cancer incidence.人乳头瘤病毒疫苗接种对感染率、宫颈异常和癌症发病率的长期影响。
Epidemiology. 2011 Jul;22(4):505-15. doi: 10.1097/EDE.0b013e31821d107b.